Robert Bitner, country manager of Galderma Poland, give his first impressions of the Polish dermatology landscape and how his past experiences have prepared him for the challenges ahead. Additionally, he highlights the importance of establishing strong partnerships with Polish medical personnel for long-term success and the potential of the company’s newest area, aesthetic dermatology.
After many years in the ophthalmology sector, you made a large shift towards dermatology, taking up the country manager role at Galderma Poland earlier this year. What was the reasoning behind this move and what similarities have you witnessed thus far within each distinct therapeutic area?
"Galderma Poland is very strong in Rx and has been our core business for years, achieving still double-digit growth in 2017, a challenging task considering the saturation of the Polish dermatology market."
